首页|炎症微生态响应TAS2R14/SIgA/TSLP通过肺-肠轴以射干麻黄汤及苦泄方调控寒哮大鼠上皮细胞屏障的机制研究

炎症微生态响应TAS2R14/SIgA/TSLP通过肺-肠轴以射干麻黄汤及苦泄方调控寒哮大鼠上皮细胞屏障的机制研究

扫码查看
探讨射干麻黄汤及其苦味药组通过肺-肠轴调控苦味受体14(TAS2R14)/分泌型免疫球蛋白A(SIgA)/胸腺基质淋巴细胞生成素(TSLP)干预寒哮大鼠上皮细胞屏障的机制。将50只SD大鼠随机分为5组,空白组、模型组、地塞米松组、射干麻黄汤组、苦味药组,10%鸡卵清白蛋白(OVA)腹腔及腹股沟两侧皮下注射致敏,联合2%OVA雾化及寒冷(2~4℃)刺激,激发大鼠寒哮模型。射干麻黄汤组、苦味药组、地塞米松组灌胃及雾化,空白组、模型组以生理盐水灌胃及雾化。末次激发后,对大鼠肺、肠组织进行苏木素-伊红(HE)染色、碘酸雪夫(PAS)染色观察肺、肠病理性变化;观察肺功能第1秒用力呼气量占用力肺活量比(FEV1/FVC)、用力呼气量为25%~75%肺活量时的平均流量/用力肺活量(FEV25%~75%/FVC)、最大呼气流量(PEF)及肺阻力(RL);酶联免疫吸附测定法(ELISA)检测血清中白细胞介素(IL)-4、IL-5、IL-13、肿瘤坏死因子(TNF)-α的含量,血清、肠与支气管黏膜中SIgA的含量;蛋白免疫印迹法检测大鼠肺组织TAS2R14蛋白表达情况;气相色谱-质谱联用法(GC-MS)测定大鼠粪便中短链脂肪酸(SCFAs)的含量;实验观察苦味药组含药血清通过TAS2R14/TSLP对脂多糖(LPS)诱导的上皮细胞炎症反应,蛋白免疫印迹法检测细胞中TAS2R14、TSLP蛋白表达。结果显示,与空白组相比,模型组大鼠饮水、饮食及体质量等均下降,肺与肠道炎性细胞浸润,杯状细胞增生,FEV1/FVC、FEV25%~75%/FVC、PEF均显著下降,RL显著上升,血清中IL-4、IL-5、IL-13和TNF-α含量均升高,血清、肠与支气管黏膜中SIgA均显著降低,肺组织中TAS2R14的表达抑制,粪便中乙酸、丙酸、丁酸含量均显著降低;LPS组TSLP表达上升,TAS2R14表达抑制。与模型组相比,射干麻黄汤、苦味药组大鼠一般情况均好转,肺与肠道炎性细胞浸润、杯状细胞增生均有所改善;FEV1/FVC、FEV25%~75%/FVC、PEF显著上升,RL显著下降;血清中L-4、IL-5、IL-13和TNF-α含量均显著降低,血清、肠与支气管黏膜中SIgA均显著升高,肺组织中TAS2R14的表达激活,粪便中乙酸、丙酸、丁酸含量均显著升高。与模型组相比,苦味药组含药血清及激动剂组TSLP表达抑制,TAS2R14表达上升。结果表明,射干麻黄汤及苦味药均可减轻哮喘大鼠肺、肠炎症反应,改善其肺功能,调节肠道SCFAs含量,其中射干麻黄汤组与苦味药组对TAS2R14蛋白的表达无明显差异,提示其临床药效的发挥,可能与苦味药组激活苦味受体TAS2R14干预肺肠上皮细胞免疫炎症介质水平相关。
Mechanism of inflammatory microecological response to TAS2R14/SIgA/TSLP in regulating epithelial cell barrier in cold asthma rats through lung-gut axis by using Shegan Mahuang Decoction and bitter and purging Chinese herbs
This study aimed to investigate the mechanism by which Shegan Mahuang Decoction (SGMH) and its bitter Chinese herbs (BCHs) regulated the lung-gut axis through the bitter taste receptor 14 (TAS2R14)/secretory immunoglobulin A (SIgA)/thymic stromal lymphopoietin (TSLP) to intervene in the epithelial cell barrier of cold asthma rats.Fifty SD rats were randomly divided into the following five groups:normal group,model group,dexamethasone group,SGMH group,and BCHs group.A 10% ovalbumin (OVA) solution was used to sensitize the rats via subcutaneous injection on both sides of the abdomen and groin,combined with 2% OVA atomization and cold (2-4 ℃) stimulation to induce a cold asthma model in rats.The SGMH,BCHs,and dexamethasone groups were given corresponding treatments by gavage and nebulization,while the normal and model groups received normal saline by gavage and nebulization.After the final stimulation,pathological changes in the lung and intestine tissues were observed using hematoxylin-eosin (HE) and periodic acid-Schiff (PAS) staining.Lung function was assessed by measuring the ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC),the ratio of the average flow rate at 25%-75% of forced vital capacity to foned vital capacity (FEV25%-75%/FVC),the peak expiratory flow (PEF),and pulmonary resistance (RL).The levels of IL-4,IL-5,IL-13,and TNF-α in serum,and sIgA in serum,intestinal,and bronchial mucosa were detected by enzyme-linked immunosorbent assay (ELISA).The expression of TAS2R14 protein in lung tissue was detected by Western blot (WB).The content of short-chain fatty acids (SCFAs) in rat feces was determined by gas chromatography-mass spectrometry (GC-MS).The effect of TAS2R14/TSLP on lipopolysaccharide (LPS)-induced inflammation in epithelial cells in the BCHs group was observed,and the expression of TAS2R14 and TSLP in cells was detected by WB.Compared with the normal group,the model group showed reduced water intake,diet,and body weight,increased infiltration of inflammatory cells in the lung and intestinal tissues,goblet cell hyperplasia,significantly decreased FEV1/FVC,FEV25%-75%/FVC,and PEF,and significantly increased RL.Moreover,serum levels of IL-4,IL-5,IL-13,and TNF-α were elevated,and sIgA levels in serum,intestine,and bronchial mucosa were significantly decreased.TAS2R14 expression in lung tissues was inhibited,and the content of acetic acid,propionic acid,and butyric acid in feces was significantly reduced.In the LPS group,TSLP expression increased,and TAS2R14 expression decreased.Compared with the model group,the general condition of rats in the SGMH and BCHs groups improved,with reduced infiltration of inflammatory cells and goblet cell hyperplasia in the lung and intestinal tissues.FEV1/FVC,FEV25%-75%/FVC,and PEF significantly increased,and RL significantly decreased.Serum levels of IL-4,IL-5,IL-13,and TNF-α decreased,while sIgA levels in serum,intestine,and bronchial mucosa significantly increased,and TAS2R14 expression was activated in lung and intestinal tissues.The content of acetic acid,propionic acid,and butyric acid in feces significantly increased.Compared with the model group,the BCHs group and the agonist group showed inhibited TSLP expression and increased TAS2R14 expression.The results showed that both SGMH and BCHs could reduce lung and intestinal inflammatory reactions,improve lung function,and regulate the content of intestinal SCFAs in asthmatic rats.There was no significant difference in TAS2R14 protein expression between the SGMH and BCHs groups,indicating that the clinical efficacy of BCHs may be related to the activation of the bitter receptor TAS2R14 and the regulation of immune inflammatory mediators in lung and intestinal epithelial cells.

Shegan Mahuang Decoctionbitter Chinese herbsTAS2R14SIgASCFAs

袁亚美、叶卫东、程悦、李秋慧、刘家鑫、乔佳乐、王坤、方向明

展开 >

安徽中医药大学,安徽合肥 230012

中医药防治肺系重大疾病应用转化安徽省重点实验室,安徽合肥 230031

新安医学教育部重点实验室,安徽合肥 230038

安徽中医药大学第二附属医院,安徽合肥 230031

展开 >

射干麻黄汤 苦味药 TAS2R14 SIgA SCFAs

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(24)